4//SEC Filing
Regnante Keith 4
Accession 0001209191-20-023990
CIK 0001664710other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 9:02 PM ET
Size
8.1 KB
Accession
0001209191-20-023990
Insider Transaction Report
Form 4
Regnante Keith
CHIEF FINANCIAL OFFICER
Transactions
- Award
Employee Stock Option (right to buy)
2020-04-07+133,622→ 133,622 totalExercise: $16.00Exp: 2030-04-06→ Common Stock (133,622 underlying) - Award
Employee Stock Option (right to buy)
2020-04-07+18,430→ 18,430 totalExercise: $16.00Exp: 2030-04-06→ Common Stock (18,430 underlying)
Footnotes (2)
- [F1]One-fourth (1/4th) of the shares subject to the option shall vest on March 1, 2021, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
- [F2]One-fourth (1/4th) of the shares subject to the option shall vest on February 24, 2021, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Keros Therapeutics, Inc.
CIK 0001664710
Entity typeother
Related Parties
1- filerCIK 0001682068
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 9:02 PM ET
- Size
- 8.1 KB